SYNERGEN EXPANDS INTO EUROPE
SYNERGEN EXPANDS INTO EUROPE BOULDER, Colo., Nov. 25 /PRNewswire/ -- Synergen Inc.
(NASDAQ: SYGN) announced today it has recruited its first employee in Europe, Nigel G. Goodman. He will assume the position of director of European marketing and business affairs for Synergen's European operation, to be located in Amsterdam, The Netherlands.
Goodman joins Synergen after a 17-year career at Hoffmann-La Roche, where he served, among numerous positions of increasing responsibility, as international product manager for Roferon, Roche's first biopharmaceutical product. He then served as project team leader of the Amgen-Roche G-CSF joint venture. Goodman later became the Amgen-Roche marketing director, overseeing the joint venture's Neupogen interests in Europe, Latin America, the Middle East and Pacific Rim. Most recently, Goodman was an account director at Gardiner Caldwell Communications, which provides medical education services to the pharmaceutical industry. Goodman is a graduate of the University of Liverpool with a B.S. in Physiology. He also received a degree in management studies from the Manchester University Business School. Synergen is a biopharmaceutical company engaged in the discovery, development and manufacture of protein-based pharmaceuticals. -0- 11/25/91 /CONTACT: Debra Catz Bannister of Synergen, 303-938-6242/ (SYGN) CO: Synergen Inc. ST: Colorado IN: MTC SU:
BB -- DV003 -- 6922 11/25/91 14:26 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 25, 1991|
|Previous Article:||PENSION BENEFIT GUARANTY CORPORATION'S TOP 50 LIST SHOWS INCREASED UNDERFUNDING|
|Next Article:||GENERAL MOTORS ANNOUNCES SIGNING OF FIRST MULTI-CITY DISTRIBUTOR OF NORTH AMERICAN VEHICLES IN THE SOVIET UNION|